2021年第二卷第二期上线！| MedComm

MedComm最新一期文章已于6月在官网上线（https://onlinelibrary.wiley.com/toc/26882663/2021/2/2，点击文末“阅读原文”查看），MedComm对所有原创性研究文章进行严格同行评审，文章上线即可免费阅读，引用和共享。

｜MedComm｜

Volume 2, Issue 2 June 2021

# Contents #

Reviews

Biodegradable magnesium-based biomaterials: An overview of challenges and opportunities

Shukufe Amukarimi and Masoud Mozafari*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.59

Novel cell sources for bone regeneration

Chenshuang Li, Zane Mills, and Zhong Zheng*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.51

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

Qian-Ying Zhu, Ge-Xin Zhao, Yan Li, Girish Talakatta, Hai-Qiang Mai, Quynh-Thu Le, Lawrence S. Young, and Mu-Sheng Zeng*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.32

Neoantigen-reactive T cell: An emerging role in adoptive cellular immunotherapy

Yicheng Zhu, Youkun Qian, Zhile Li, Yangyang Li*, and Bin Li*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.41

Original Articles

Insights on the structure–function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies

Jing-Quan Wang, Qingbin Cui, Zi-Ning Lei, Qiu-Xu Teng, Ning Ji, Lusheng Lin, Zhijun Liu*, and Zhe-Sheng Chen*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.65

Alleviating the toxicity concerns of antibacterial cinnamon-polycaprolactone biomaterials for healthcare-related biomedical applications

Jubair Ahmed, Merve Gultekinoglu, Cem Bayram, Didem Kart, Kezban Ulubayram, and Mohan Edirisinghe*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.71

Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19

Jing-Jing Wang, Yun-Juan Su, Qi Wang, Ying Cao*, Ai-Bin Wang, Rui Ding, and Wen Xie*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.66

Administration of fusion cytokines induces tumor regression and systemic antitumor immunity

Jinyu Zhang* and Xuan Zhao

https://onlinelibrary.wiley.com/doi/10.1002/mco2.68

UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients

Jiaxi Chen, Chong Liu, Shenyi Ye, Ruyue Lu*, Hongguo Zhu*, and Jiaqin Xu*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.67

Nicotinamide mononucleotide ameliorates senescence in alveolar epithelial cells

Tingting Fang, Jingyun Yang, Li Liu, Hengyi Xiao*, and Xiawei Wei*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.62

Letter to the Editor

Risk factors associated with deep vein thrombosis in COVID-19 patients

Bin Wang, Li Zhang, Shanye Yin, Wenjun Deng*, and Mingxing Xie*

https://onlinelibrary.wiley.com/doi/10.1002/mco2.52

Journal关于期刊

MedComm是科研和教育领域的全球领导者——Wiley公司出版发行的全英文生物医学专业期刊（https://onlinelibrary.wiley.com/journal/26882663）。

主编由英国牛津大学James Henderson Naismith教授（英国皇家科学院院士、英国皇家爱丁堡科学院院士）、耶鲁大学Günter P. Wagner教授（美国国家科学院院士、美国科学促进会院士、美国艺术与科学院院士）和四川大学华西医院生物治疗国家重点实验室魏于全教授（中国科学院院士）担任，副主编与编委由全球10多个国家的著名科学家构成。

MedComm是同行评审的在线发表开放获取 (OA) 期刊，及时出版关于生物医学领域的基础研究与临床研究方面的工作，力争成为生物医学领域中具有国际影响力的高质量SCI学术期刊。本期刊发表论文类型包括综述（Review）、展望（Perspective）、研究论文（Research Article）、致编辑信函（Letter）、研究亮点（Research Highlight）等，对于原创性成果采取“快速通道”模式，帮助作者以最快的速度发表文章，最快一周可接收，并于2020年至2022年之间免收论文出版费。此外，投稿时文章格式不限，正式接收发表时再按本期刊要求修改。

MedComm竭诚欢迎生物医学领域的科研工作者、医生、研究生积极向期刊投稿！

往期精选

内容 | 四川省国际医学交流促进会（SCIMEA）

点击免费浏览新一期